Back

Potential of comorbidity indices and CHA2DS2-VASc to predict ischemic stroke and mortality in patients with atrial fibrillation: a validation study

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Insights on prognosis and outcome of common arrhythmia disorders Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Mr Kasper Bonnesen

Copenhagen University Hospital, Copenhagen (Denmark)

8 More presentations in this session

Presentation thumbnail
Atrial fibrillation in patients with Graves disease: incidence, risk factors and outcomes
Doctor J. Naser (Rochester, US)
Abstract Slides
Presentation thumbnail
Incidence of thyroid dysfunction following initiation of amiodarone treatment in patients with and without heart failure: a nationwide cohort study
Mr S. Ali (Copenhagen, DK)
Abstract Slides
Presentation thumbnail
Recurrence of atrial fibrillation following pulmonary vein isolation: impact of body mass index on one- and three-year outcomes
Ms N. Milstein (Paramus, US)
Abstract Slides
Presentation thumbnail
Prognosis and antithrombotic practice patterns in recurrent and transient atrial fibrillation following acute coronary syndrome: a nationwide study
Mr L. Ostergaard (Copenhagen, DK)
Abstract Slides
Presentation thumbnail
Incidence of atrial fibrillation/flutter, one-year re-admission rates, and practice patterns among patients <65 years of age: a Danish nationwide study
Mr L. Schak Nielsen (Copenhagen, DK)
Abstract Slides

Access the full session

Session thumbnail
Insights on prognosis and outcome of common arrhythmia disorders

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources